As leaders in the field of regenerative veterinary medicine, we are proud to announce that we have reached a new stem cell processing milestone. VetStem has processed over 15,000 patient samples resulting in over 35,000 stem cell treatments for animals across the United States and Canada. Over 2,200 veterinarians have utilized VetStem Cell Therapy processing services for their patients.

The majority of these treatments have been for orthopedic conditions such as osteoarthritis as well as injured tendons and ligaments in dogs, cats, and horses. We have also provided cell therapy services for patients with alternate conditions such as renal disease, inflammatory bowel disease, gingivostomatitis, spinal conditions, and more as part of our clinical research programs.

While most know that we primarily work with domestic animals, we also work with multiple exotic animal organizations and their programs to provide stem cell therapy for several exotic species. To date, nearly 200 exotic animals have been treated. Those animals include elephants, cheetahs, rhinos, several species of bears, giraffes, penguins, dolphins and more.

We are very proud to be leaders in this field of cutting-edge medicine. And we look forward to what the future holds! That being said, we wouldn’t be where we are without all of YOU, our pet owners and veterinary clients, who have trusted VetStem to handle your pets’ and patients’ stem cells over the past nearly two decades. Thank you from the bottom of our hearts!

The American College of Regenerative Medicine (ACRM) has asked VetStem CEO, Dr. Bob Harman, to join their board of directors. As the CEO and co-founder of both VetStem and human subsidiary, Personalized Stem Cells, Inc. (PSC), Dr. Harman has nearly two decades of experience working with stem cells and regenerative medicine.

The first of its kind, the ACRM is a multi-specialty, interdisciplinary medical organization. The ACRM was formed to promote the science and ethical use of regenerative medicine with a strong emphasis on global interdisciplinary collaboration. Board members include medical doctors and surgeons, a dentist, a registered nurse and our very own veterinarian, Dr. Harman.

The ACRM’s mission statement encompasses everything from physician and patient education to safety and scientific advancement. While regenerative medicine and stem cell therapy is not new, there is still much to learn about regenerative cell therapies. The ACRM is fully committed to patient safety and a high standard of care. Like VetStem and PSC, the ACRM advocates for patient safety by following FDA guidelines and maintaining compliance.

The interdisciplinary focus of the ACRM will allow for the amalgamation of knowledge and expertise from doctors across multiple fields. Dr. Harman brings nearly two decades of experience with regenerative medicine in the veterinary field to share. With the launch of PSC in 2018, Dr. Harman can also provide insight into human regenerative medicine and FDA approved stem cell clinical trials. We hope this “One Medicine” approach will ultimately lead to understanding regenerative cell therapies more fully and open the door for additional FDA approved regenerative treatment options.